SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $213,008,589 |
| Positions | 19 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| INVESCO QQQ TR | Unresolved | PUT | $36,820,000 | 50,000 |
| ADMA BIOLOGICS INC | ADMA | COM | $27,307,477 | 3,262,542 |
| PALISADE BIO INC | PALI | COM | $23,855,856 | 11,414,285 |
| NRX PHARMACEUTICALS INC | NRXP | COM NEW | $16,735,327 | 4,091,767 |
| FAETH THERAPEUTICS INC | FTH | COM NEW | $15,254,225 | 610,169 |
| TAYSHA GENE THERAPIES INC | TSHA | COM SHS | $12,261,786 | 1,800,556 |
| PRAXIS PRECISION MEDICINES I | PRAX | COM NEW | $11,127,415 | 33,237 |
| CELLECTIS S A | CLLS | SPON ADS | $9,844,503 | 3,281,501 |
| ZAI LAB LTD | ZLAB | ADR | $8,562,274 | 450,646 |
| STRUCTURE THERAPEUTICS INC | GPCR | SPONSORED ADS | $7,513,800 | 140,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.